GTC
Ghost Tree Capital’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-425,000
| Closed | -$3.44M | – | 56 |
|
|
2023
Q1 | $3.44M | Buy |
+425,000
| New | +$3.44M | 1.02% | 31 |
|
|
2022
Q2 | – | Sell |
-125,000
| Closed | -$2.16M | – | 30 |
|
|
2022
Q1 | $2.16M | Sell |
125,000
-200,000
| -62% | -$3.45M | 0.47% | 28 |
|
|
2021
Q4 | $4.73M | Buy |
325,000
+50,000
| +18% | +$727K | 1.69% | 20 |
|
|
2021
Q3 | $4.95M | Buy |
275,000
+25,000
| +10% | +$450K | 1.45% | 22 |
|
|
2021
Q2 | $4.39M | Sell |
250,000
-350,000
| -58% | -$6.15M | 1.21% | 30 |
|
|
2021
Q1 | $15.1M | Sell |
600,000
-50,000
| -8% | -$1.26M | 3.55% | 8 |
|
|
2020
Q4 | $4.21M | Buy |
+650,000
| New | +$4.21M | 0.94% | 28 |
|
|
2017
Q1 | – | Sell |
-120,000
| Closed | -$3.26M | – | 58 |
|
|
2016
Q4 | $3.26M | Sell |
120,000
-55,000
| -31% | -$1.49M | 0.78% | 40 |
|
|
2016
Q3 | $4.48M | Buy |
+175,000
| New | +$4.48M | 0.73% | 32 |
|